Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: a prospective observational study.
Xiufang KongYing SunXiaojuan DaiLi WangZongfei JiHuiyong ChenXuejuan JinLili MaLin-di JiangPublished in: Annals of the rheumatic diseases (2021)
TOF was superior to MTX for CR induction, a tendency to prevent relapse and tapering of the GCs dose in TAK treatment. A good safety profile for TOF was also documented in patients with TAK.